drugset / Trial / NCT00579280
Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD
RandomizedParallel-groupDouble-blindTreatment
Summary
The specific aim of this study is to evaluate the efficacy, tolerability, and safety of quetiapine SR monotherapy and divalproex sodium ER monotherapy in comparison to placebo in the treatment of ambulatory bipolar disorder with co-morbid lifetime panic disorder or generalized anxiety disorder and current at least moderately severe anxiety.
Timeline
- Start
- 2007-07
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Divalproex Sodium | Small molecule | 500 mg | — |
| Comparator | Divalproex Sodium | Small molecule | 3000 mg | — |
| Comparator | Quetiapine | Small molecule | 50 mg | — |
| Comparator | Quetiapine | Small molecule | 300 mg | — |